Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323What this trial is testingDuvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RSWho this might be right forChronic Lymphocytic LeukemiaRichter Syndrome Dana-Farber Cancer Institute 55
Early research (Phase 1)Ended earlyNCT04804254What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell CancersWho this might be right forB-cell Lymphoma AbbVie 5
Testing effectiveness (Phase 2)Study completedNCT00738829What this trial is testingLenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLLWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Arbeitsgemeinschaft medikamentoese Tumortherapie 45
Testing effectiveness (Phase 2)Study completedNCT01011894What this trial is testingLenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of AgeWho this might be right forChronic Lymphocytic LeukemiaLeukemia Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)WithdrawnNCT01754870What this trial is testingPhase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00004002What this trial is testingPS-341 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health
Not applicableStudy completedNCT01178086What this trial is testingA Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 681
Early research (Phase 1)WithdrawnNCT05037669What this trial is testingProgrammed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Not applicableNot Yet RecruitingNCT07463976What this trial is testingVariaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia PathwayWho this might be right forChronic Lymphocytic LeukemiaHaematological Malignancy The Royal Wolverhampton Hospitals NHS Trust 130
Early research (Phase 1)Ended earlyNCT00882076What this trial is testingClofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasWho this might be right forLeukemia Milton S. Hershey Medical Center 22
Early research (Phase 1)UnknownNCT01619761What this trial is testingNK Cells in Cord Blood TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Study completedNCT00562380What this trial is testingAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaWho this might be right forLymphomaProstate CancerSarcoma+2 more Amgen 64
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02514083What this trial is testingA Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma National Heart, Lung, and Blood Institute (NHLBI) 29
Early research (Phase 1)WithdrawnNCT02914327What this trial is testingSafety and Activity of SNX-5422 Plus Ibrutinib in CLLWho this might be right forCancer Esanex Inc.
Testing effectiveness (Phase 2)Study completedNCT01930162What this trial is testingSafety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood TransplantWho this might be right forSingle Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT01650727What this trial is testingDinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Merck Sharp & Dohme LLC 5